Matches in Nanopublications for { ?s <http://purl.org/dc/terms/description> ?o ?g. }
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Systems level analysis and identification of pathways and networks associated with liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The patient is heterozygous for an alteration in the A2M gene; this may be responsible for his serum A2M deficiency and may be relevant to the early onset of pulmonary disease in his case.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The patient is heterozygous for an alteration in the A2M gene; this may be responsible for his serum A2M deficiency and may be relevant to the early onset of pulmonary disease in his case.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP5248.RA2HaX2npqyWFpE9RK37QX4T-vWYssfXSdPdgyfyLy1Qc130_assertion description "[The patient is heterozygous for an alteration in the A2M gene; this may be responsible for his serum A2M deficiency and may be relevant to the early onset of pulmonary disease in his case.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP5248.RA2HaX2npqyWFpE9RK37QX4T-vWYssfXSdPdgyfyLy1Qc130_provenance.
- NP600134.RAJJPNEHV0s0gW__TtZxm6GdHogeuoiNmWMxON9ehRe-s130_assertion description "[The patient is heterozygous for an alteration in the A2M gene; this may be responsible for his serum A2M deficiency and may be relevant to the early onset of pulmonary disease in his case.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP600134.RAJJPNEHV0s0gW__TtZxm6GdHogeuoiNmWMxON9ehRe-s130_provenance.
- NP217226.RACwfuQ-RoxsSw3l1YgDvoTWQBZqNwaAyGkIdKBWItFX8130_assertion description "[The patient is heterozygous for an alteration in the A2M gene; this may be responsible for his serum A2M deficiency and may be relevant to the early onset of pulmonary disease in his case.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217226.RACwfuQ-RoxsSw3l1YgDvoTWQBZqNwaAyGkIdKBWItFX8130_provenance.
- NP1175607.RAsnjrbXvOx-nIHb3rkbPrEFT7tSk1lOtX3jh554eev2U130_assertion description "[The patient is heterozygous for an alteration in the A2M gene; this may be responsible for his serum A2M deficiency and may be relevant to the early onset of pulmonary disease in his case.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175607.RAsnjrbXvOx-nIHb3rkbPrEFT7tSk1lOtX3jh554eev2U130_provenance.
- assertion description "[Trypsin binding activity of alpha 2-macroglobulin in cystic fibrosis and other lung diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP892262.RAiFSfHFQq9WLYt14aYycNBBa6Wb_qFp80Q7d0hD5jMfU130_assertion description "[Trypsin binding activity of alpha 2-macroglobulin in cystic fibrosis and other lung diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP892262.RAiFSfHFQq9WLYt14aYycNBBa6Wb_qFp80Q7d0hD5jMfU130_provenance.
- NP217227.RARx_J9gN0SvaecEBG5vdOQqY1-dK7s69Jk7YTtca65Zo130_assertion description "[Trypsin binding activity of alpha 2-macroglobulin in cystic fibrosis and other lung diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217227.RARx_J9gN0SvaecEBG5vdOQqY1-dK7s69Jk7YTtca65Zo130_provenance.
- NP1304887.RAiepV3ezHRoJ5fg67YfwMZAuKrAxzQKIlqKYEYdeXAgc130_assertion description "[Trypsin binding activity of alpha 2-macroglobulin in cystic fibrosis and other lung diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1304887.RAiepV3ezHRoJ5fg67YfwMZAuKrAxzQKIlqKYEYdeXAgc130_provenance.
- NP1304888.RAl3ETehwJZUmlGFc7etEN6BZq8ghSQyc-cD5DneYhtyU130_assertion description "[Trypsin binding activity of alpha 2-macroglobulin in cystic fibrosis and other lung diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1304888.RAl3ETehwJZUmlGFc7etEN6BZq8ghSQyc-cD5DneYhtyU130_provenance.
- NP217213.RAyhpZj6pZC9qc2rdrAfLTQhTNH6D1X38Fq-EQY2e0EKg130_assertion description "[Trypsin binding activity of alpha 2-macroglobulin in cystic fibrosis and other lung diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217213.RAyhpZj6pZC9qc2rdrAfLTQhTNH6D1X38Fq-EQY2e0EKg130_provenance.
- NP565480.RAcV9OKcY6bTDTP7dc9ePTRQ02TtZUphL3nPvEgCdp3-Y130_assertion description "[The highest alpha 2-macroglobulin concentrations were found in the PI Q0 patients (5 with emphysema, 2 with no lung disease), and these patients had almost no circulating alpha 1-antitrypsin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP565480.RAcV9OKcY6bTDTP7dc9ePTRQ02TtZUphL3nPvEgCdp3-Y130_provenance.
- assertion description "[The highest alpha 2-macroglobulin concentrations were found in the PI Q0 patients (5 with emphysema, 2 with no lung disease), and these patients had almost no circulating alpha 1-antitrypsin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP217228.RAYmTD159bsXjd0nvovpJ36rhcihMkJLv8_mwhl7o_QM0130_assertion description "[The highest alpha 2-macroglobulin concentrations were found in the PI Q0 patients (5 with emphysema, 2 with no lung disease), and these patients had almost no circulating alpha 1-antitrypsin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217228.RAYmTD159bsXjd0nvovpJ36rhcihMkJLv8_mwhl7o_QM0130_provenance.
- NP1305033.RAhCJepO5Msm48Lm2-J6L1ZpyHtwbt9piGX2YHOCNryNc130_assertion description "[The highest alpha 2-macroglobulin concentrations were found in the PI Q0 patients (5 with emphysema, 2 with no lung disease), and these patients had almost no circulating alpha 1-antitrypsin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1305033.RAhCJepO5Msm48Lm2-J6L1ZpyHtwbt9piGX2YHOCNryNc130_provenance.
- assertion description "[The aim is to describe the involvement of matrix metalloprotease (MMP), A Disintegrin And Metalloproteases (ADAM), tissue inhibitors of MMP (TIMP) polymorphisms and the role of ?-2 Macroglobulin (?-2M) in chronic obstructive pulmonary disease (COPD) development and progression, with a focus on interventions with synthetic MMP inhibitors alone or associated with current drugs used in COPD therapy in order to restore MMPs/TIMPs imbalance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP665218.RAq57cnXmBwjbRRPqAV-Xb8IiLAg7OZAvcQZ8MJFDRM3Y130_assertion description "[The aim is to describe the involvement of matrix metalloprotease (MMP), A Disintegrin And Metalloproteases (ADAM), tissue inhibitors of MMP (TIMP) polymorphisms and the role of ?-2 Macroglobulin (?-2M) in chronic obstructive pulmonary disease (COPD) development and progression, with a focus on interventions with synthetic MMP inhibitors alone or associated with current drugs used in COPD therapy in order to restore MMPs/TIMPs imbalance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665218.RAq57cnXmBwjbRRPqAV-Xb8IiLAg7OZAvcQZ8MJFDRM3Y130_provenance.
- NP456035.RAKfoQ8lGymd09RCvVr-Kf0NLJeXzc-QUJJ8fdX3g6El8130_assertion description "[The aim is to describe the involvement of matrix metalloprotease (MMP), A Disintegrin And Metalloproteases (ADAM), tissue inhibitors of MMP (TIMP) polymorphisms and the role of ?-2 Macroglobulin (?-2M) in chronic obstructive pulmonary disease (COPD) development and progression, with a focus on interventions with synthetic MMP inhibitors alone or associated with current drugs used in COPD therapy in order to restore MMPs/TIMPs imbalance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP456035.RAKfoQ8lGymd09RCvVr-Kf0NLJeXzc-QUJJ8fdX3g6El8130_provenance.
- NP217230.RAjNrjb0MDwZuAgEBjrVoCv7NRsLIoJEgtn0KZjNkMlDg130_assertion description "[The aim is to describe the involvement of matrix metalloprotease (MMP), A Disintegrin And Metalloproteases (ADAM), tissue inhibitors of MMP (TIMP) polymorphisms and the role of ?-2 Macroglobulin (?-2M) in chronic obstructive pulmonary disease (COPD) development and progression, with a focus on interventions with synthetic MMP inhibitors alone or associated with current drugs used in COPD therapy in order to restore MMPs/TIMPs imbalance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217230.RAjNrjb0MDwZuAgEBjrVoCv7NRsLIoJEgtn0KZjNkMlDg130_provenance.
- NP950156.RAsqwC3wJMixESf38kk-hhwdO6ft43BrXyZiQQquxGl1Y130_assertion description "[The aim is to describe the involvement of matrix metalloprotease (MMP), A Disintegrin And Metalloproteases (ADAM), tissue inhibitors of MMP (TIMP) polymorphisms and the role of ?-2 Macroglobulin (?-2M) in chronic obstructive pulmonary disease (COPD) development and progression, with a focus on interventions with synthetic MMP inhibitors alone or associated with current drugs used in COPD therapy in order to restore MMPs/TIMPs imbalance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP950156.RAsqwC3wJMixESf38kk-hhwdO6ft43BrXyZiQQquxGl1Y130_provenance.
- assertion description "[Notably, expression of alpha-2-macroglobulin, transthyretin, alpha-1-antitrypsin, and properdin was in common in different lung tumor models, but regulation of orosomucoid-8, apolipoprotein-A1, apolipoprotein-C3, apolipoprotein-E, glutathione peroxidase-3, plasma retinol-binding protein, and serum amyloid P component was unique when the serum proteomes of c-myc and c-raf tumor bearing mice were compared.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP7179.RAaC5p4nZGUMstdZGrLjhXi84oSvMnAyqMoacrNPjbLjU130_assertion description "[Notably, expression of alpha-2-macroglobulin, transthyretin, alpha-1-antitrypsin, and properdin was in common in different lung tumor models, but regulation of orosomucoid-8, apolipoprotein-A1, apolipoprotein-C3, apolipoprotein-E, glutathione peroxidase-3, plasma retinol-binding protein, and serum amyloid P component was unique when the serum proteomes of c-myc and c-raf tumor bearing mice were compared.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP7179.RAaC5p4nZGUMstdZGrLjhXi84oSvMnAyqMoacrNPjbLjU130_provenance.
- NP8879.RA15nDouKNLvzpLg0wrncf8hjdDhg-ktKdRe7FfVRwo0Q130_assertion description "[Notably, expression of alpha-2-macroglobulin, transthyretin, alpha-1-antitrypsin, and properdin was in common in different lung tumor models, but regulation of orosomucoid-8, apolipoprotein-A1, apolipoprotein-C3, apolipoprotein-E, glutathione peroxidase-3, plasma retinol-binding protein, and serum amyloid P component was unique when the serum proteomes of c-myc and c-raf tumor bearing mice were compared.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP8879.RA15nDouKNLvzpLg0wrncf8hjdDhg-ktKdRe7FfVRwo0Q130_provenance.
- NP8922.RA5DTWNrHnIExE9PfSkmyNiFL0F6SXK5YKM0QHK0jGWE4130_assertion description "[Notably, expression of alpha-2-macroglobulin, transthyretin, alpha-1-antitrypsin, and properdin was in common in different lung tumor models, but regulation of orosomucoid-8, apolipoprotein-A1, apolipoprotein-C3, apolipoprotein-E, glutathione peroxidase-3, plasma retinol-binding protein, and serum amyloid P component was unique when the serum proteomes of c-myc and c-raf tumor bearing mice were compared.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP8922.RA5DTWNrHnIExE9PfSkmyNiFL0F6SXK5YKM0QHK0jGWE4130_provenance.
- NP33125.RAURrqv2gMq5wzkmvdmCygSBo3Pq-3GtAuRUOf4HuNZGg130_assertion description "[Notably, expression of alpha-2-macroglobulin, transthyretin, alpha-1-antitrypsin, and properdin was in common in different lung tumor models, but regulation of orosomucoid-8, apolipoprotein-A1, apolipoprotein-C3, apolipoprotein-E, glutathione peroxidase-3, plasma retinol-binding protein, and serum amyloid P component was unique when the serum proteomes of c-myc and c-raf tumor bearing mice were compared.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33125.RAURrqv2gMq5wzkmvdmCygSBo3Pq-3GtAuRUOf4HuNZGg130_provenance.
- assertion description "[Notably, expression of alpha-2-macroglobulin, transthyretin, alpha-1-antitrypsin, and properdin was in common in different lung tumor models, but regulation of orosomucoid-8, apolipoprotein-A1, apolipoprotein-C3, apolipoprotein-E, glutathione peroxidase-3, plasma retinol-binding protein, and serum amyloid P component was unique when the serum proteomes of c-myc and c-raf tumor bearing mice were compared.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Notably, expression of alpha-2-macroglobulin, transthyretin, alpha-1-antitrypsin, and properdin was in common in different lung tumor models, but regulation of orosomucoid-8, apolipoprotein-A1, apolipoprotein-C3, apolipoprotein-E, glutathione peroxidase-3, plasma retinol-binding protein, and serum amyloid P component was unique when the serum proteomes of c-myc and c-raf tumor bearing mice were compared.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Notably, expression of alpha-2-macroglobulin, transthyretin, alpha-1-antitrypsin, and properdin was in common in different lung tumor models, but regulation of orosomucoid-8, apolipoprotein-A1, apolipoprotein-C3, apolipoprotein-E, glutathione peroxidase-3, plasma retinol-binding protein, and serum amyloid P component was unique when the serum proteomes of c-myc and c-raf tumor bearing mice were compared.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP7218.RA8AX-AY1WxkfQNyUq4zeOYgok6cOXCIMG188uZUw6y6U130_assertion description "[Notably, expression of alpha-2-macroglobulin, transthyretin, alpha-1-antitrypsin, and properdin was in common in different lung tumor models, but regulation of orosomucoid-8, apolipoprotein-A1, apolipoprotein-C3, apolipoprotein-E, glutathione peroxidase-3, plasma retinol-binding protein, and serum amyloid P component was unique when the serum proteomes of c-myc and c-raf tumor bearing mice were compared.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP7218.RA8AX-AY1WxkfQNyUq4zeOYgok6cOXCIMG188uZUw6y6U130_provenance.
- NP7170.RApjQ_qErNMMXh1TeB4TXZkSZl4vi048X2vG_Ctz7OT_M130_assertion description "[Notably, expression of alpha-2-macroglobulin, transthyretin, alpha-1-antitrypsin, and properdin was in common in different lung tumor models, but regulation of orosomucoid-8, apolipoprotein-A1, apolipoprotein-C3, apolipoprotein-E, glutathione peroxidase-3, plasma retinol-binding protein, and serum amyloid P component was unique when the serum proteomes of c-myc and c-raf tumor bearing mice were compared.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP7170.RApjQ_qErNMMXh1TeB4TXZkSZl4vi048X2vG_Ctz7OT_M130_provenance.
- NP5250.RAET5z-NQvBNMrpVjWDo8HR3TjF3N_aZgjap1pD8LqkLY130_assertion description "[Notably, expression of alpha-2-macroglobulin, transthyretin, alpha-1-antitrypsin, and properdin was in common in different lung tumor models, but regulation of orosomucoid-8, apolipoprotein-A1, apolipoprotein-C3, apolipoprotein-E, glutathione peroxidase-3, plasma retinol-binding protein, and serum amyloid P component was unique when the serum proteomes of c-myc and c-raf tumor bearing mice were compared.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP5250.RAET5z-NQvBNMrpVjWDo8HR3TjF3N_aZgjap1pD8LqkLY130_provenance.
- assertion description "[Notably, expression of alpha-2-macroglobulin, transthyretin, alpha-1-antitrypsin, and properdin was in common in different lung tumor models, but regulation of orosomucoid-8, apolipoprotein-A1, apolipoprotein-C3, apolipoprotein-E, glutathione peroxidase-3, plasma retinol-binding protein, and serum amyloid P component was unique when the serum proteomes of c-myc and c-raf tumor bearing mice were compared.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP33638.RANfxefDZJRuVxZJNFpgFcsqfcfvFeB4ceoTpcAEnK7jc130_assertion description "[Notably, expression of alpha-2-macroglobulin, transthyretin, alpha-1-antitrypsin, and properdin was in common in different lung tumor models, but regulation of orosomucoid-8, apolipoprotein-A1, apolipoprotein-C3, apolipoprotein-E, glutathione peroxidase-3, plasma retinol-binding protein, and serum amyloid P component was unique when the serum proteomes of c-myc and c-raf tumor bearing mice were compared.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33638.RANfxefDZJRuVxZJNFpgFcsqfcfvFeB4ceoTpcAEnK7jc130_provenance.
- NP7121.RAPldTsTEjxF8qwaGayiZSJypq6hUK-1gun5yHpDr-8uk130_assertion description "[Notably, expression of alpha-2-macroglobulin, transthyretin, alpha-1-antitrypsin, and properdin was in common in different lung tumor models, but regulation of orosomucoid-8, apolipoprotein-A1, apolipoprotein-C3, apolipoprotein-E, glutathione peroxidase-3, plasma retinol-binding protein, and serum amyloid P component was unique when the serum proteomes of c-myc and c-raf tumor bearing mice were compared.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP7121.RAPldTsTEjxF8qwaGayiZSJypq6hUK-1gun5yHpDr-8uk130_provenance.
- assertion description "[Notably, we demonstrate significant regulation of alpha-1-antitrypsin, alpha-2-macroglobulin, hemoglobin subunit alpha, vitamin D-binding protein, major urinary proteins, and transthyretin (up to eight-fold) in serum of lung tumor bearing mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP16529.RA8EAlAMx1SByqmR_vPHQ_iEPlac_ktZtIf0yrqARxTwg130_assertion description "[Notably, we demonstrate significant regulation of alpha-1-antitrypsin, alpha-2-macroglobulin, hemoglobin subunit alpha, vitamin D-binding protein, major urinary proteins, and transthyretin (up to eight-fold) in serum of lung tumor bearing mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP16529.RA8EAlAMx1SByqmR_vPHQ_iEPlac_ktZtIf0yrqARxTwg130_provenance.
- NP33124.RAkY20OgtmTAJrJfasSa9Jgr0Mr7mvQZEmpDFZPxmwNko130_assertion description "[Notably, we demonstrate significant regulation of alpha-1-antitrypsin, alpha-2-macroglobulin, hemoglobin subunit alpha, vitamin D-binding protein, major urinary proteins, and transthyretin (up to eight-fold) in serum of lung tumor bearing mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33124.RAkY20OgtmTAJrJfasSa9Jgr0Mr7mvQZEmpDFZPxmwNko130_provenance.
- NP7178.RACzDCFz-phe5nuhX5BzPKl0K5bUqd_i9htjsoVSQM8VM130_assertion description "[Notably, we demonstrate significant regulation of alpha-1-antitrypsin, alpha-2-macroglobulin, hemoglobin subunit alpha, vitamin D-binding protein, major urinary proteins, and transthyretin (up to eight-fold) in serum of lung tumor bearing mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP7178.RACzDCFz-phe5nuhX5BzPKl0K5bUqd_i9htjsoVSQM8VM130_provenance.
- assertion description "[Notably, we demonstrate significant regulation of alpha-1-antitrypsin, alpha-2-macroglobulin, hemoglobin subunit alpha, vitamin D-binding protein, major urinary proteins, and transthyretin (up to eight-fold) in serum of lung tumor bearing mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP15541.RA2dW7NGqo41HrWO4_701YU-IjF2bVPL19CMDVghhwiRY130_assertion description "[Notably, we demonstrate significant regulation of alpha-1-antitrypsin, alpha-2-macroglobulin, hemoglobin subunit alpha, vitamin D-binding protein, major urinary proteins, and transthyretin (up to eight-fold) in serum of lung tumor bearing mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP15541.RA2dW7NGqo41HrWO4_701YU-IjF2bVPL19CMDVghhwiRY130_provenance.
- NP5249.RAk3pMuEwNs5onScx7KgVWUUAdjfCNYsHxkIwkxW7o6H0130_assertion description "[Notably, we demonstrate significant regulation of alpha-1-antitrypsin, alpha-2-macroglobulin, hemoglobin subunit alpha, vitamin D-binding protein, major urinary proteins, and transthyretin (up to eight-fold) in serum of lung tumor bearing mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP5249.RAk3pMuEwNs5onScx7KgVWUUAdjfCNYsHxkIwkxW7o6H0130_provenance.
- NP29406.RA7CeLogHAjQ2aNDP542UfCW_L8_xvTPRwACtYjZ7n5XY130_assertion description "[Notably, we demonstrate significant regulation of alpha-1-antitrypsin, alpha-2-macroglobulin, hemoglobin subunit alpha, vitamin D-binding protein, major urinary proteins, and transthyretin (up to eight-fold) in serum of lung tumor bearing mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP29406.RA7CeLogHAjQ2aNDP542UfCW_L8_xvTPRwACtYjZ7n5XY130_provenance.
- NP33637.RA31Cchs-WdDswbxO_hkjVW0pvhb3aJdTlcbNf-RvfQus130_assertion description "[Notably, we demonstrate significant regulation of alpha-1-antitrypsin, alpha-2-macroglobulin, hemoglobin subunit alpha, vitamin D-binding protein, major urinary proteins, and transthyretin (up to eight-fold) in serum of lung tumor bearing mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33637.RA31Cchs-WdDswbxO_hkjVW0pvhb3aJdTlcbNf-RvfQus130_provenance.
- assertion description "[Notably, we demonstrate significant regulation of alpha-1-antitrypsin, alpha-2-macroglobulin, hemoglobin subunit alpha, vitamin D-binding protein, major urinary proteins, and transthyretin (up to eight-fold) in serum of lung tumor bearing mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Notably, we demonstrate significant regulation of alpha-1-antitrypsin, alpha-2-macroglobulin, hemoglobin subunit alpha, vitamin D-binding protein, major urinary proteins, and transthyretin (up to eight-fold) in serum of lung tumor bearing mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The TREM2 variant is associated with: (i) AD (odds ratio: 4.76; P = .014); (ii) increased density of amyloid plaques and neurofibrillary tangles in multiple brain regions; (iii) increased TREM2 (P = .041) and TYROBP (P = .006) gene expression; (iv) decreased TREM2 protein levels (P = .016); and (v) upregulation of proinflammatory cytokines (regulated on activation, normal T cell expressed and secreted [RANTES] and interferon [IFN] gamma) (P = .003) and nominal downregulation of protective markers (?2-macroglobulin, interleukin 4 or IL-4, and ApoA1) (P = .018).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The TREM2 variant is associated with: (i) AD (odds ratio: 4.76; P = .014); (ii) increased density of amyloid plaques and neurofibrillary tangles in multiple brain regions; (iii) increased TREM2 (P = .041) and TYROBP (P = .006) gene expression; (iv) decreased TREM2 protein levels (P = .016); and (v) upregulation of proinflammatory cytokines (regulated on activation, normal T cell expressed and secreted [RANTES] and interferon [IFN] gamma) (P = .003) and nominal downregulation of protective markers (?2-macroglobulin, interleukin 4 or IL-4, and ApoA1) (P = .018).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The TREM2 variant is associated with: (i) AD (odds ratio: 4.76; P = .014); (ii) increased density of amyloid plaques and neurofibrillary tangles in multiple brain regions; (iii) increased TREM2 (P = .041) and TYROBP (P = .006) gene expression; (iv) decreased TREM2 protein levels (P = .016); and (v) upregulation of proinflammatory cytokines (regulated on activation, normal T cell expressed and secreted [RANTES] and interferon [IFN] gamma) (P = .003) and nominal downregulation of protective markers (?2-macroglobulin, interleukin 4 or IL-4, and ApoA1) (P = .018).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The TREM2 variant is associated with: (i) AD (odds ratio: 4.76; P = .014); (ii) increased density of amyloid plaques and neurofibrillary tangles in multiple brain regions; (iii) increased TREM2 (P = .041) and TYROBP (P = .006) gene expression; (iv) decreased TREM2 protein levels (P = .016); and (v) upregulation of proinflammatory cytokines (regulated on activation, normal T cell expressed and secreted [RANTES] and interferon [IFN] gamma) (P = .003) and nominal downregulation of protective markers (?2-macroglobulin, interleukin 4 or IL-4, and ApoA1) (P = .018).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The TREM2 variant is associated with: (i) AD (odds ratio: 4.76; P = .014); (ii) increased density of amyloid plaques and neurofibrillary tangles in multiple brain regions; (iii) increased TREM2 (P = .041) and TYROBP (P = .006) gene expression; (iv) decreased TREM2 protein levels (P = .016); and (v) upregulation of proinflammatory cytokines (regulated on activation, normal T cell expressed and secreted [RANTES] and interferon [IFN] gamma) (P = .003) and nominal downregulation of protective markers (?2-macroglobulin, interleukin 4 or IL-4, and ApoA1) (P = .018).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The TREM2 variant is associated with: (i) AD (odds ratio: 4.76; P = .014); (ii) increased density of amyloid plaques and neurofibrillary tangles in multiple brain regions; (iii) increased TREM2 (P = .041) and TYROBP (P = .006) gene expression; (iv) decreased TREM2 protein levels (P = .016); and (v) upregulation of proinflammatory cytokines (regulated on activation, normal T cell expressed and secreted [RANTES] and interferon [IFN] gamma) (P = .003) and nominal downregulation of protective markers (?2-macroglobulin, interleukin 4 or IL-4, and ApoA1) (P = .018).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The TREM2 variant is associated with: (i) AD (odds ratio: 4.76; P = .014); (ii) increased density of amyloid plaques and neurofibrillary tangles in multiple brain regions; (iii) increased TREM2 (P = .041) and TYROBP (P = .006) gene expression; (iv) decreased TREM2 protein levels (P = .016); and (v) upregulation of proinflammatory cytokines (regulated on activation, normal T cell expressed and secreted [RANTES] and interferon [IFN] gamma) (P = .003) and nominal downregulation of protective markers (?2-macroglobulin, interleukin 4 or IL-4, and ApoA1) (P = .018).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The TREM2 variant is associated with: (i) AD (odds ratio: 4.76; P = .014); (ii) increased density of amyloid plaques and neurofibrillary tangles in multiple brain regions; (iii) increased TREM2 (P = .041) and TYROBP (P = .006) gene expression; (iv) decreased TREM2 protein levels (P = .016); and (v) upregulation of proinflammatory cytokines (regulated on activation, normal T cell expressed and secreted [RANTES] and interferon [IFN] gamma) (P = .003) and nominal downregulation of protective markers (?2-macroglobulin, interleukin 4 or IL-4, and ApoA1) (P = .018).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The TREM2 variant is associated with: (i) AD (odds ratio: 4.76; P = .014); (ii) increased density of amyloid plaques and neurofibrillary tangles in multiple brain regions; (iii) increased TREM2 (P = .041) and TYROBP (P = .006) gene expression; (iv) decreased TREM2 protein levels (P = .016); and (v) upregulation of proinflammatory cytokines (regulated on activation, normal T cell expressed and secreted [RANTES] and interferon [IFN] gamma) (P = .003) and nominal downregulation of protective markers (?2-macroglobulin, interleukin 4 or IL-4, and ApoA1) (P = .018).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The TREM2 variant is associated with: (i) AD (odds ratio: 4.76; P = .014); (ii) increased density of amyloid plaques and neurofibrillary tangles in multiple brain regions; (iii) increased TREM2 (P = .041) and TYROBP (P = .006) gene expression; (iv) decreased TREM2 protein levels (P = .016); and (v) upregulation of proinflammatory cytokines (regulated on activation, normal T cell expressed and secreted [RANTES] and interferon [IFN] gamma) (P = .003) and nominal downregulation of protective markers (?2-macroglobulin, interleukin 4 or IL-4, and ApoA1) (P = .018).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The TREM2 variant is associated with: (i) AD (odds ratio: 4.76; P = .014); (ii) increased density of amyloid plaques and neurofibrillary tangles in multiple brain regions; (iii) increased TREM2 (P = .041) and TYROBP (P = .006) gene expression; (iv) decreased TREM2 protein levels (P = .016); and (v) upregulation of proinflammatory cytokines (regulated on activation, normal T cell expressed and secreted [RANTES] and interferon [IFN] gamma) (P = .003) and nominal downregulation of protective markers (?2-macroglobulin, interleukin 4 or IL-4, and ApoA1) (P = .018).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The TREM2 variant is associated with: (i) AD (odds ratio: 4.76; P = .014); (ii) increased density of amyloid plaques and neurofibrillary tangles in multiple brain regions; (iii) increased TREM2 (P = .041) and TYROBP (P = .006) gene expression; (iv) decreased TREM2 protein levels (P = .016); and (v) upregulation of proinflammatory cytokines (regulated on activation, normal T cell expressed and secreted [RANTES] and interferon [IFN] gamma) (P = .003) and nominal downregulation of protective markers (?2-macroglobulin, interleukin 4 or IL-4, and ApoA1) (P = .018).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The TREM2 variant is associated with: (i) AD (odds ratio: 4.76; P = .014); (ii) increased density of amyloid plaques and neurofibrillary tangles in multiple brain regions; (iii) increased TREM2 (P = .041) and TYROBP (P = .006) gene expression; (iv) decreased TREM2 protein levels (P = .016); and (v) upregulation of proinflammatory cytokines (regulated on activation, normal T cell expressed and secreted [RANTES] and interferon [IFN] gamma) (P = .003) and nominal downregulation of protective markers (?2-macroglobulin, interleukin 4 or IL-4, and ApoA1) (P = .018).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The TREM2 variant is associated with: (i) AD (odds ratio: 4.76; P = .014); (ii) increased density of amyloid plaques and neurofibrillary tangles in multiple brain regions; (iii) increased TREM2 (P = .041) and TYROBP (P = .006) gene expression; (iv) decreased TREM2 protein levels (P = .016); and (v) upregulation of proinflammatory cytokines (regulated on activation, normal T cell expressed and secreted [RANTES] and interferon [IFN] gamma) (P = .003) and nominal downregulation of protective markers (?2-macroglobulin, interleukin 4 or IL-4, and ApoA1) (P = .018).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Alpha-2-macroglobulin (alpha-2M; encoded by the gene A2M) is a serum pan-protease inhibitor that has been implicated in Alzheimer disease (AD) based on its ability to mediate the clearance and degradation of A beta, the major component of beta-amyloid deposits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP310640.RAkxt4hauaADI_PBXs1kNRl5I-vdxtLX-ybwm6WDHsV7E130_assertion description "[Alpha-2-macroglobulin (alpha-2M; encoded by the gene A2M) is a serum pan-protease inhibitor that has been implicated in Alzheimer disease (AD) based on its ability to mediate the clearance and degradation of A beta, the major component of beta-amyloid deposits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP310640.RAkxt4hauaADI_PBXs1kNRl5I-vdxtLX-ybwm6WDHsV7E130_provenance.
- assertion description "[Alpha-2-macroglobulin (alpha-2M; encoded by the gene A2M) is a serum pan-protease inhibitor that has been implicated in Alzheimer disease (AD) based on its ability to mediate the clearance and degradation of A beta, the major component of beta-amyloid deposits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Alpha-2-macroglobulin (alpha-2M; encoded by the gene A2M) is a serum pan-protease inhibitor that has been implicated in Alzheimer disease (AD) based on its ability to mediate the clearance and degradation of A beta, the major component of beta-amyloid deposits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1401378.RAVD605i6cz7a4NEQCLMPlHFEUAXnyRSvkBmpvOlgwhiE130_assertion description "[Alpha-2-macroglobulin (alpha-2M; encoded by the gene A2M) is a serum pan-protease inhibitor that has been implicated in Alzheimer disease (AD) based on its ability to mediate the clearance and degradation of A beta, the major component of beta-amyloid deposits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1401378.RAVD605i6cz7a4NEQCLMPlHFEUAXnyRSvkBmpvOlgwhiE130_provenance.
- NP1401377.RAA0qbuoMYbOp5g6tELQbhs3BCvGgJQGq9cMKUQVYhESw130_assertion description "[Alpha-2-macroglobulin (alpha-2M; encoded by the gene A2M) is a serum pan-protease inhibitor that has been implicated in Alzheimer disease (AD) based on its ability to mediate the clearance and degradation of A beta, the major component of beta-amyloid deposits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1401377.RAA0qbuoMYbOp5g6tELQbhs3BCvGgJQGq9cMKUQVYhESw130_provenance.
- NP217274.RAG7TK0z-FWUXaZsnpevweY5Nk3Rr1hj5pNgagNJxwkr4130_assertion description "[Alpha-2-macroglobulin (alpha-2M; encoded by the gene A2M) is a serum pan-protease inhibitor that has been implicated in Alzheimer disease (AD) based on its ability to mediate the clearance and degradation of A beta, the major component of beta-amyloid deposits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217274.RAG7TK0z-FWUXaZsnpevweY5Nk3Rr1hj5pNgagNJxwkr4130_provenance.
- NP989872.RAMHjj82azSthCFgHK22sGO033r6IfmQ8k8dMzHxa9CDE130_assertion description "[Alpha-2-macroglobulin (alpha-2M; encoded by the gene A2M) is a serum pan-protease inhibitor that has been implicated in Alzheimer disease (AD) based on its ability to mediate the clearance and degradation of A beta, the major component of beta-amyloid deposits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP989872.RAMHjj82azSthCFgHK22sGO033r6IfmQ8k8dMzHxa9CDE130_provenance.
- NP989512.RA4JcusEfq72UjNTx5_O0BBxXrY8O1vUyRcQ8heuALJyM130_assertion description "[Alpha-2-macroglobulin (alpha-2M; encoded by the gene A2M) is a serum pan-protease inhibitor that has been implicated in Alzheimer disease (AD) based on its ability to mediate the clearance and degradation of A beta, the major component of beta-amyloid deposits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP989512.RA4JcusEfq72UjNTx5_O0BBxXrY8O1vUyRcQ8heuALJyM130_provenance.
- NP1401374.RA0fi_6r7eYTxr5rMpM1HKQgo84Tm_2pShvdnImSTDzus130_assertion description "[Alpha-2-macroglobulin (alpha-2M; encoded by the gene A2M) is a serum pan-protease inhibitor that has been implicated in Alzheimer disease (AD) based on its ability to mediate the clearance and degradation of A beta, the major component of beta-amyloid deposits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1401374.RA0fi_6r7eYTxr5rMpM1HKQgo84Tm_2pShvdnImSTDzus130_provenance.
- assertion description "[increased alpha (2) -macroglobulin expression appears to be associated with benign prostatic hyperplasia]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.